2025-04-01 2026-03-31 false No description of principal activity Capium Accounts Production 1.1 09131315 2025-04-01 2026-03-31 09131315 bus:AbridgedAccounts 2025-04-01 2026-03-31 09131315 bus:Micro-entities 2025-04-01 2026-03-31 09131315 bus:AuditExemptWithAccountantsReport 2025-04-01 2026-03-31 09131315 bus:SmallCompaniesRegimeForAccounts 2025-04-01 2026-03-31 09131315 bus:PrivateLimitedCompanyLtd 2025-04-01 2026-03-31 09131315 2025-04-01 2026-03-31 09131315 2026-03-31 09131315 bus:RegisteredOffice 2025-04-01 2026-03-31 09131315 core:WithinOneYear 2026-03-31 09131315 core:AfterOneYear 2026-03-31 09131315 1 2025-04-01 2026-03-31 09131315 bus:Director1 2025-04-01 2026-03-31 09131315 bus:Director1 2026-03-31 09131315 bus:Director1 2024-04-01 2025-03-31 09131315 bus:Director2 2025-04-01 2026-03-31 09131315 bus:Director2 2026-03-31 09131315 bus:Director2 2024-04-01 2025-03-31 09131315 2024-04-01 09131315 bus:CompanySecretary1 2025-04-01 2026-03-31 09131315 bus:LeadAgentIfApplicable 2025-04-01 2026-03-31 09131315 2024-04-01 2025-03-31 09131315 2025-03-31 09131315 core:WithinOneYear 2025-03-31 09131315 core:AfterOneYear 2025-03-31 09131315 bus:EntityAccountantsOrAuditors 2024-04-01 2025-03-31 09131315 bus:OrdinaryShareClass1 2025-04-01 2026-03-31 09131315 bus:OrdinaryShareClass1 2026-03-31 09131315 bus:OrdinaryShareClass1 2024-04-01 2025-03-31 09131315 bus:OrdinaryShareClass1 2025-03-31 09131315 bus:OrdinaryShareClass2 2025-04-01 2026-03-31 09131315 bus:OrdinaryShareClass2 2026-03-31 09131315 bus:OrdinaryShareClass2 2024-04-01 2025-03-31 09131315 bus:OrdinaryShareClass2 2025-03-31 09131315 bus:OrdinaryShareClass3 2025-04-01 2026-03-31 09131315 bus:OrdinaryShareClass3 2026-03-31 09131315 bus:OrdinaryShareClass3 2024-04-01 2025-03-31 09131315 bus:OrdinaryShareClass3 2025-03-31 09131315 bus:OrdinaryShareClass4 2025-04-01 2026-03-31 09131315 bus:OrdinaryShareClass4 2026-03-31 09131315 bus:OrdinaryShareClass4 2024-04-01 2025-03-31 09131315 bus:OrdinaryShareClass4 2025-03-31 09131315 bus:OrdinaryShareClass5 2025-04-01 2026-03-31 09131315 bus:OrdinaryShareClass5 2026-03-31 09131315 bus:OrdinaryShareClass5 2024-04-01 2025-03-31 09131315 bus:OrdinaryShareClass5 2025-03-31 09131315 bus:OrdinaryShareClass6 2025-04-01 2026-03-31 09131315 bus:OrdinaryShareClass6 2026-03-31 09131315 bus:OrdinaryShareClass6 2024-04-01 2025-03-31 09131315 bus:OrdinaryShareClass6 2025-03-31 09131315 bus:OrdinaryShareClass7 2025-04-01 2026-03-31 09131315 bus:OrdinaryShareClass7 2026-03-31 09131315 bus:OrdinaryShareClass7 2024-04-01 2025-03-31 09131315 bus:OrdinaryShareClass7 2025-03-31 09131315 bus:OrdinaryShareClass8 2025-04-01 2026-03-31 09131315 bus:OrdinaryShareClass8 2026-03-31 09131315 bus:OrdinaryShareClass8 2024-04-01 2025-03-31 09131315 bus:OrdinaryShareClass8 2025-03-31 09131315 core:FurnitureFittings 2025-04-01 2026-03-31 09131315 core:FurnitureFittings 2026-03-31 09131315 core:FurnitureFittings 2025-03-31 09131315 core:LeasedAssetsHeldAsLessee core:PlantMachinery 2026-03-31 09131315 core:LeasedAssetsHeldAsLessee core:PlantMachinery 2025-03-31 09131315 core:CostValuation core:Non-currentFinancialInstruments 2026-03-31 09131315 core:CostValuation core:Non-currentFinancialInstruments 2025-03-31 09131315 core:AdditionsToInvestments core:Non-currentFinancialInstruments 2026-03-31 09131315 core:DisposalsDecreaseInInvestments core:Non-currentFinancialInstruments 2026-03-31 09131315 core:RevaluationsIncreaseDecreaseInInvestments core:Non-currentFinancialInstruments 2026-03-31 09131315 core:Non-currentFinancialInstruments 2026-03-31 09131315 core:Non-currentFinancialInstruments 2025-03-31 iso4217:GBP xbrli:shares xbrli:pure
Registered Number: 09131315
England and Wales

 

 

 

MS ENDOSCOPY LTD



Abridged Accounts
 


Period of accounts

Start date: 01 April 2025

End date: 31 March 2026
  2026   2025
    £ £   £ £
Fixed assets   1,905      2,540 
Current assets 114,629      120,872   
Creditors: amount falling due within one year (116,054)     (122,855)  
Net current assets   (1,425)     (1,983)
Total assets less current liabilities   480      557 
Provisions for liabilities   (480)     (537)
Net assets       20 
 

         
Capital and reserves       20 
 
NOTES TO THE ACCOUNTS

General Information
MS Endoscopy Ltd is a private company, limited by shares, registered in England and Wales, registration number 09131315, registration address 19 The Bramblings, Castleford, West Yorkshire, WF10 5ER.

The presentation currency is £ sterling.
1.

Accounting policies

Significant accounting policies
Statement of compliance
These financial statements have been prepared in compliance with FRS 105 – The Financial Reporting Standard applicable in the UK and Republic of Ireland and the Companies Act 2006.
Basis of preparation
The financial statements have been prepared under the historical cost convention.
The financial statements are prepared in sterling which is the functional currency of the company.
2.

Average number of employees


Average number of employees during the year was 2 (2025 : 2).

3.

Director’s loan

Directors Loan Account

At 31st March 2026, the Directors Loan Account of £16,009 (2025 £24,794) is unsecured, repayable on demand and currently interest free. During the period the directors incurred the following transactions:


Director's Loan Account   Balance b/fwd
£
  Advances
£
  Credit
£
  Balance c/fwd
£
Director (24,794) 55,937  (47,152) 16,009 


For the year ended 31 March 2026 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' Responsibilities:
The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts.

These accounts have been prepared in accordance with the micro-entity provisions and FRS 105, the Financial Reporting Standard applicable to the micro-entities regime. The accounts have been delivered in accordance with the provisions applicable to companies subject to the small companies regime. The income statement has not been delivered to the Registrar of Companies.

The members have agreed to the preparation of abridged accounts.
The financial statements were approved by the board of directors on 08 April 2026 and were signed on its behalf by:


--------------------------------
M B S Shetty
Director
1